{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:28Z","timestamp":1783149508598,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015723","name":"University of Clermont Auvergne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.radonc.2026.111620","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:24:29Z","timestamp":1780417469000},"page":"111620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1202-0019","authenticated-orcid":false,"given":"Fanny","family":"Beltzung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Biau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-7161","authenticated-orcid":false,"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-2010","authenticated-orcid":false,"given":"Nicolas","family":"Saroul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pham Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Boutault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Darcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-5492","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9rique","family":"Penault-Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-7803","authenticated-orcid":false,"given":"Emmanuel","family":"Chautard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.radonc.2026.111620_b0005","first-page":"42","article-title":"Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma","volume":"11","author":"Barsouk","year":"2023","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"10.1016\/j.radonc.2026.111620_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2026.111620_b0015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188128","article-title":"Immunotherapeutic strategies in head and neck cancer: challenges and opportunities","volume":"135","author":"Liu","year":"2025","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1016\/j.radonc.2026.111620_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2014.07.005","article-title":"Radiotherapy and immunogenic cell death","volume":"25","author":"Golden","year":"2015","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2026.111620_b0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.seminoncol.2019.07.003","article-title":"Ionizing radiation effects on the tumor microenvironment","volume":"46","author":"Portella","year":"2019","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1016\/j.radonc.2026.111620_b0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/cells14110789","article-title":"Spatial distribution and prognostic value of T cell subtypes and immune biomarkers in p16-Negative HNSCC","volume":"14","author":"Krum","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.radonc.2026.111620_b0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.2013.640","article-title":"Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer","volume":"110","author":"Balermpas","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.radonc.2026.111620_b0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00784-017-2099-x","article-title":"Biological predictors of radiosensitivity in head and neck squamous cell carcinoma","volume":"22","author":"Fiedler","year":"2018","journal-title":"Clin Oral Investig"},{"issue":"7 Pt 1","key":"10.1016\/j.radonc.2026.111620_b0045","first-page":"728","article-title":"Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis","volume":"105","author":"Mart\u00ednez-Gimeno","year":"1995","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.radonc.2026.111620_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/his.14357","article-title":"Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma","volume":"79","author":"Sakai","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.radonc.2026.111620_b0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1016\/j.radonc.2026.111620_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104094","article-title":"Leveraging deep learning for immune cell quantification and prognostic evaluation in radiotherapy-treated oropharyngeal squamous cell carcinomas","volume":"105","author":"Beltzung","year":"2025","journal-title":"Lab Invest"},{"issue":"Suppl.","key":"10.1016\/j.radonc.2026.111620_b0065","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","article-title":"Principles and analytical performance of Abbott RealTime High Risk HPV test","volume":"45","author":"Huang","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.radonc.2026.111620_b0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of Tumor Infiltrating Leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.radonc.2026.111620_b0075","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1614858","article-title":"Characterization of the tumor immune micromilieu and its interference with outcome after concurrent chemoradiation in patients with oropharyngeal carcinomas","volume":"8","author":"Hess","year":"2019","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.radonc.2026.111620_b0080","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12105-023-01590-6","article-title":"Assessing PD-L1 expression in head and neck squamous cell carcinoma: trials and tribulations","volume":"17","author":"Bill","year":"2023","journal-title":"Head Neck Pathol"},{"issue":"4","key":"10.1016\/j.radonc.2026.111620_b0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbrc.2016.03.161","article-title":"MAGE-A1 promotes melanoma proliferation and migration through C-JUN activation","volume":"473","author":"Wang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.radonc.2026.111620_b0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12672-025-01804-z","article-title":"A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets","volume":"16","author":"Li","year":"2025","journal-title":"Discov Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2026.111620_b0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ijc.28752","article-title":"Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer","volume":"135","author":"Laban","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.radonc.2026.111620_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s10020-025-01079-8","article-title":"Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy","volume":"31","author":"Zhu","year":"2025","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.radonc.2026.111620_b0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41419-020-2627-5","article-title":"The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.radonc.2026.111620_b0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41420-024-01833-7","article-title":"IL-8 activates fibroblasts to promote the invasion of HNSCC cells via STAT3-MMP1","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"issue":"59","key":"10.1016\/j.radonc.2026.111620_b0115","doi-asserted-by":"crossref","first-page":"100280","DOI":"10.18632\/oncotarget.22213","article-title":"The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma","volume":"8","author":"Schutt","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2026.111620_b0120","article-title":"Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma","volume":"161","author":"Kannan","year":"2024","journal-title":"Arch Oral Biol mai"},{"key":"10.1016\/j.radonc.2026.111620_b0125","article-title":"Crosstalk between head and neck cancer cells and lymphatic endothelial cells promotes tumor metastasis via CXCL5-CXCR2 signaling","volume":"35","author":"Lee","year":"2021","journal-title":"FASEB J janv"},{"key":"10.1016\/j.radonc.2026.111620_b0130","article-title":"CXCL5: a coachman to drive cancer progression","volume":"12","author":"Deng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111620_b0135","doi-asserted-by":"crossref","unstructured":"Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement System Part II: Role in Immunity. Front Immunol [Internet]. 26 mai 2015 [cit\u00e9 30 juill 2025];6. Disponible sur: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2015.00257\/full.","DOI":"10.3389\/fimmu.2015.00257"},{"key":"10.1016\/j.radonc.2026.111620_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2024.1335648","article-title":"IDO1 correlates with the immune landscape of head and neck squamous cell carcinoma: a study based on bioinformatics analyses","volume":"5","author":"Gkountana","year":"2024","journal-title":"Front Oral Health"},{"key":"10.1016\/j.radonc.2026.111620_b0145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00262-022-03313-2","article-title":"Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy","volume":"72","author":"Rutihinda","year":"2023","journal-title":"Cancer Immunol Immunother mai"},{"key":"10.1016\/j.radonc.2026.111620_b0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fmed.2018.00271","article-title":"The Role of CXCR3 and its Chemokine Ligands in Skin Disease and Cancer","volume":"5","author":"Kuo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.radonc.2026.111620_b0155","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41598-025-86185-7","article-title":"FLT3 is associated with dendritic cell infiltration, tertiary lymphoid structure construction, and predict response to checkpoint inhibitors immunotherapy in solid cancers","volume":"15","author":"Tang","year":"2025","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.radonc.2026.111620_b0160","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/15592294.2017.1365207","article-title":"PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma","volume":"12","author":"Kurimoto","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.radonc.2026.111620_b0165","article-title":"IL-21 is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:46:59Z","timestamp":1783147619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026004597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0167814026004597"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111620","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111620"}}